TRIER PHARM ApS: Financial statements 2018
CVR: 31611083
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 470,000 and a net result of DKK -21,000 compared with DKK 1,772 the year before. That is a decrease of 2.3% compared with the year before. The profit margin was -4.5%. Equity in the 2018 report amounted to DKK -380,103.
- Revenue
- DKK 470,000
- Gross Profit
- DKK -3,129
- Profit/Loss
- DKK -21,000
- Equity
- DKK -380,103
- Total Assets
- DKK 367,495
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 470 t. | -3 t. | -21 t. | -380 t. | - |
| 2017 | 481 t. | 20 t. | 2 t. | -359 t. | - |
| 2016 | 494 t. | 179 t. | -600 t. | -361 t. | - |
| 2015 | 594 t. | -209 t. | -232 t. | 239 t. | - |
| 2014 | 387 t. | -272 t. | -285 t. | 471 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
TRIER PHARM ApS has published its annual report for 2017. Revenue came to DKK 481,250, and the net result was DKK 1,772.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.